Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PACB | PRCT |
|---|---|---|
| Price | $2.72 | $17.91 |
| Change today | ▲ 0.74% | ▲ 2.28% |
| Market cap | $845.46M | $1.03B |
| Return, 3 months | +68.9% | -9.3% |
| Return, year to date | +45.5% | -43.1% |
| Return, 1 year | +80.1% | -48.5% |
| P/E (TTM) | -6.5 | -9.2 |
| P/B | -25.4 | 3.0 |
| P/E percentile vs own 5y | 35th | 91st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -1.9% | +19.3% |
| Net profit growth (YoY) | -6.7% | -37.2% |
| Gross margin | 36.4% | 64.2% |
| Operating margin | -102.6% | -33.9% |
| Net margin | -82.5% | -32.5% |
| Return on equity | -929.3% | -30.2% |
| Analyst target vs. price | -23.5% | +29.8% |
| Analyst buy share | 50% | 36% |
| RSI (14) | 80 | 43 |
| 30-day volatility | 105.9% | 55.8% |
| Max drawdown, 1 year | -58.4% | -54.9% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
